TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk Patients

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Uterine Fibroids (Leiomyoma), Ovarian Tumors, Gallstones

In brief

The goal of this clinical trial is to evaluate the effects of transcutaneous electrical acupoint stimulation (TEAS) combined with triple antiemetics for postoperative nausea and vomiting (PONV) in high-risk patients. The primary question it seeks to answer is: Does TEAS combined with triple antiemetics further reduce the incidence of PONV in high-risk subjects? Researchers will compare active TEAS with sham stimulation to determine whether the addition of TEAS to dexamethasone, palonosetron, and droperidol lowers the PONV rate beyond that achieved by the triple-drug prophylaxis alone.

Key facts

Study ID
NCT07480785
Run by
Zhejiang University
People needed
780
Starts
2026-01-16
Expected to finish
2027-10-31
Last updated by the study team
2026-03-18

Who can join

Age: 18 and older, up to 65. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.